Page 9 - Jamie Christensen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jamie christensen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jamie Christensen Today - Breaking & Trending Today

Mirati Therapeutics (NASDAQ:MRTX) Given New $62.00 Price Target at Oppenheimer

Mirati Therapeutics (NASDAQ:MRTX – Free Report) had its target price lifted by Oppenheimer from $56.00 to $62.00 in a research report released on Wednesday morning, MarketBeat reports. They currently have an outperform rating on the biotechnology company’s stock. MRTX has been the subject of a number of other reports. BMO Capital Markets decreased their price […] ....

United States , Jamie Christensen , Laurie Stelzer , Granahan Investment Management , Edmond De Rothschild Holding , Mirati Therapeutics Company Profile , Advisors Inc , Fiera Capital Corp , Mirati Therapeutics Inc , Mirati Therapeutics , Free Report , Get Free Report , Capital Corp , Mirati Therapeutics Daily , Nasdaq Mrtx , Boost Price Target , Oppenheimer Holdings Inc ,

Oppenheimer Boosts Mirati Therapeutics (NASDAQ:MRTX) Price Target to $62.00

Mirati Therapeutics (NASDAQ:MRTX – Free Report) had its price objective upped by Oppenheimer from $56.00 to $62.00 in a research note published on Wednesday, MarketBeat reports. They currently have an outperform rating on the biotechnology company’s stock. Other analysts have also issued research reports about the company. Scotiabank began coverage on Mirati Therapeutics in a […] ....

United States , Laurie Stelzer , Jamie Christensen , Mirati Therapeutics Company Profile , Acadian Asset Management , Metlife Investment Management , Mirati Therapeutics Inc , Advisor Group Holdings Inc , Blackrock Inc , Securities Exchange Commission , Us Bancorp , Mirati Therapeutics , Free Report , Therapeutics Trading Down , Get Free Report , Exchange Commission , Group Holdings , Asset Management , Life Investment Management , Mirati Therapeutics Daily , Nasdaq Mrtx , Boost Price Target , Oppenheimer Holdings Inc ,

B. Riley Weighs in on Mirati Therapeutics, Inc.'s Q3 2023 Earnings (NASDAQ:MRTX)

B. Riley Weighs in on Mirati Therapeutics, Inc.'s Q3 2023 Earnings (NASDAQ:MRTX)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Laurie Stelzer , Jamie Christensen , Profund Advisors , Dimensional Fund Advisors , Mirati Therapeutics Company Profile , Mirati Therapeutics Inc , Td Asset Management Inc , Securities Exchange Commission , Charles Schwab Investment Management Inc , Great West Life Assurance Co , Mirati Therapeutics , Free Report , Mirati Therapeutic , Get Free Report , Exchange Commission , West Life Assurance , Schwab Investment Management , Fund Advisors , Management Inc , Mirati Therapeutics Daily ,

Mirati Therapeutics (NASDAQ:MRTX) Stock Rating Upgraded by B. Riley

Mirati Therapeutics (NASDAQ:MRTX) Stock Rating Upgraded by B. Riley
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United States , Jamie Christensen , Stifel Nicolaus , Laurie Stelzer , Quent Capital , Headlands Technologies , Mirati Therapeutics Inc , Century Group , Morgan Stanley , Advisor Group Holdings Inc , Securities Exchange Commission , Mirati Therapeutics Company Profile , Mirati Therapeutics , Get Free Report , Marketbeat Ratings , Exchange Commission , Group Holdings , Captrust Financial Advisors , Financial Advisors , Mirati Therapeutics Daily ,

Mirati Therapeutics (NASDAQ:MRTX) Releases Earnings Results

Mirati Therapeutics (NASDAQ:MRTX – Get Free Report) announced its quarterly earnings results on Tuesday. The biotechnology company reported ($3.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($3.23) by $0.19, Briefing.com reports. Mirati Therapeutics had a negative net margin of 3,901.06% and a negative return on equity of 71.90%. The company […] ....

United States , Laurie Stelzer , Stifel Nicolaus , Jamie Christensen , Blackrock Inc , Mirati Therapeutics Inc , Goldman Sachs Group Inc , Century Group , Norges Bank , Mirati Therapeutics Company Profile , Morgan Stanley , Mirati Therapeutics , Get Free Report , Sachs Group , Mirati Therapeutics Daily , Nasdaq Mrtx ,